Hamze Rahmani
Translator — Persian
Articles translated into Persian by Hamze Rahmani
- Finding the silver lining: an update on the Roche GENERATION-HD1 trial data
- Real talk: Q&A with Roche about GENERATION-HD1
- Exciting Experiments in "Open Science" by Huntington's Researchers
- GPR52: Exploring a new way to lower huntingtin
- Drug to treat movement symptoms of HD approved by FDA
- Serious side effects reported for some people treated with the huntingtin-lowering drug AMT-130, currently in clinical trials
- Kids sometimes get Huntington’s disease too
- PROOF-HD study of pridopidine ends with negative result
- The structure of the protein that causes Huntington's disease, revealed
- Updates from uniQure about their gene therapy for Huntington's disease
- Sad news from Novartis: dosing suspended in VIBRANT-HD trial of branaplam
- Updates from PTC Therapeutics and uniQure on their huntingtin-lowering trials
- Hunting for balance: how the huntingtin protein compensates in HD
- uniQure gets the green light to resume testing HD gene therapy
- Disappointing news from Novartis about branaplam and the VIBRANT-HD trial
- Update on the PTC Therapeutics PIVOT-HD Trial
- Roche Phase II GENERATION HD2 study underway
- Start here!
- Success! ASO drug reduces levels of mutant protein in Huntington's disease patients